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Well before the COVID-19 pandemic, there was growing excitement about the potential of 
various digital technologies, especially smartphone apps, to revolutionize mental healthcare (e.g., Insel, 
2018). As the SARS-CoV-2 virus spread across the globe, representative headlines warned that 
“COVID-19 could spark a mental-health tsunami” (Urback, 2020), that lockdowns would create a 
“mental illness epidemic within the coronavirus pandemic” (Miller, 2020), and that we could see an 
“‘echo pandemic’ among traumatized health workers” (Harris, 2020). And indeed, a CDC study in 
June 2020 found that a staggering 40% of Americans reported considerably elevated adverse mental 
health conditions, a significant increase compared to the same period in 2019 (Czeisler et al., 2020). 
All of this has unfolded against a backdrop where demand for mental health services already 
outstripped the supply of available clinicians. Thus, many researchers are sounding the alarm that the 
mental health fallout from COVID-19 will persist long after vaccines are distributed, further straining 
the existing mental health infrastructure for years to come (Galea, Merchant, & Lurie, 2020; Kathirvel, 
2020).  
In response, interest in (and funding for) digital mental health technologies is surging, to the 
point that Ben-Zeev (2020) has claimed “the digital mental health genie is out of the bottle”. A 
reckoning with the ethical and social implications of these technologies is urgent because decisions 
made today will shape the future of mental healthcare for the foreseeable future. We contend that the 
existing bioethics literature on digital mental health technologies has neglected fundamental ethical 
 2 
questions related to efficacy and justice. That is, the extent to which these technologies demonstrably 
improve mental health outcomes, and the likelihood that wide-scale adoption will exacerbate the 
existing health inequalities laid bare by the pandemic. We will argue that the evidence for efficacy is 
weak and that the likelihood of increasing inequalities is high.   
Here is the plan for the paper. In Section 1, we briefly summarize recent trends in digital 
mental health. In Section 2, we note the growing calls for widespread adoption of digital mental health 
tools to address the mental health sequalae of COVID-19. In Section 3, we develop two responses. 
First, we carefully assess recent meta-analytic evidence from the clinical literature to argue that many 
technologies proposed as a response to the pandemic are unlikely to improve mental health outcomes. 
Second, we argue that even evidence-based digital mental health tools run a high risk of increasing 
health disparities. We conclude by recommending that policymakers should not allocate limited 
resources to the development of many digital mental health tools. Rather, they should focus instead 
on evidence-based solutions to address mental health inequalities. 
 
Section 1: What is digital mental health? 
To begin, a quick terminological clarification will be helpful. In order to account for the diverse 
approaches in this field, we follow the World Health Organization (2019),1 and use “Digital Mental 
Health” (DMH, henceforth) as a catchall term.2 A recent scoping review found four main application 
 
1 In their (2019) guidelines on digital interventions, the WHO defines digital health as “a broad umbrella term 
encompassing eHealth [electronic health: ‘the use of information and communications technology in support of health 
and health-related fields’], which includes mHealth [mobile health: ‘the use of mobile wireless technologies for health’], as 
well as emerging areas, such as the use of advanced computing sciences in ‘big data’, genomics and artificial intelligence.” 
Given the broad scope, this terminology best captures the variety of approaches in digital mental health as well.  
 
2 We should also note at the outset that developments in this field proceed at a breakneck pace, much faster than the 
traditional academic publishing cycle. In our experience researching this topic, it is not unusual that a digital mental health 
application will be introduced on the market, and then be re-branded, bought-out by a competitor, or disappear altogether 
within the timespan of a few months. Thus, our examples in this section are best understood as a snapshot of DMH 
technology from a particular point in time (namely, Summer/Fall 2020). Nonetheless, we made every effort to ensure our 
analyses will remain relevant to future developments in this area. 
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areas for digital mental health technologies including (1) detection and diagnosis; (2) prognosis, 
treatment and support; (3) public health, and; (4) research and clinical administration (Shatte, 
Hutchinson, & Teague, 2019). In what follows, we provide a brief summary of some recent 
developments in these areas, with a focus on (1) and (2). Smartphone apps play an outsized role here 
because they are often touted as a solution to the problem of increased demand mentioned above, 
owing to their ubiquity and scalability.3 
1.1 Smartphone apps 
Before COVID-19, much excitement and funding were generated around approaches in the 
smartphone app category and these trends are also likely to persist after the pandemic.4 According to 
one estimate, there are over 10,000 mental health smartphone apps commercially available, though 
that number is likely even higher now (Carlo et al., 2019). Much of this work has fallen under the 
heading of “digital phenotyping,” following a series of influential articles by Tom Insel, former director 
of the National Institute of Mental Health (NIMH).5  
 
3 Of course, one of the defining features of the COVID-19 pandemic has been the rapid shift and adoption of tele-
health generally, and tele-mental health specifically (e.g., use of phone, text, or video communication involved in the 
delivery of mental health services on platforms such as Doxy, Teladoc, or Mend). Before COVID-19, these services 
were often promoted as an effective means of providing mental health services to low-resources areas (Kaonga & 
Morgan, 2019) and traditionally under-served populations, including rural areas (e.g., Speyer et al., 2018; Myers, 2019), 
indigenous communities (Hensel et al., 2019), and geriatric patients (Gentry, Lapid, & Rummans, 2019). While tele-
mental health certainly fits under the broad umbrella of DMH, in contrast to some smartphone apps, many standard 
tele-health approaches lack the scalability required to address the increasing demand for mental health services (see 
Section 3.3 below for further discussion). 
4 For example, according to SensorTower the world’s top 10 combined English-language mental wellness apps 
“accumulated close to 10 million downloads, up 24.2 percent from the installs they generated in January 2020.” It of course 
remains to be seen if these trends will continue after the pandemic, but this rapid increase is undoubtedly significant. 
Retrieved from: https://sensortower.com/blog/top-mental-wellness-apps-april-2020-downloads 
5 Digital phenotyping is described as a family of “approaches in which personal data gathered from mobile devices and 
sensors are analyzed to provide health information.” (Martinez-Martin, Insel, Dagum, Greely, & Cho, 2018, p. 1). 
According to Insel, smartphones provide “an objective, passive, ubiquitous device to capture behavioral and cognitive 
information continuously,” with the potential to “transmit actionable information  to the patient and the clinician, 
improving the precision of diagnosis and enabling measurement based care at scale” (Insel, 2017, p. 1215). In turn, these 
approaches promise to “revolutionize how we measure cognition, mood, and behavior,” and “transform the diagnosis and 
treatment of mental illness globally by enabling passive, continuous, quantitative, and ecological measurement-based care” 
(Martinez-Martin, Insel, Dagum, Greely, & Cho, 2018, p. 4).  
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To cite just a few examples of the ways smartphone apps are used for treatment and support, 
consider “PTSD Coach,” a free smartphone app for anyone who has experienced trauma, “FOCUS,” 
which is geared towards patients with schizophrenia; “Sleepio,” which helps patients suffering from 
insomnia (Anthes, 2016); “Lantern,” “Joyable,” “MoodGYM,” and “Ginger.io” which connect users 
with cognitive and behavioral therapists (Topol 2019a); “7 Cups” describes itself as “the world’s largest 
emotional support system” which “connects users to caring listeners for free emotional support” and 
has over one millions installs; “Youper” is described as “a pocket AI therapist which is always there 
to talk,” with over one million installs; “Sanvello” is described as “the #1 app for stress, anxiety, and 
depression with over 3 million users.” Examples of smartphone apps in the administrative category 
include “PE Coach” or “DBT Coach”, which help clinicians to facilitate therapy by providing 
homework assignments for clients. 
Still other apps promise to improve detection and diagnosis by running in the background of 
a user’s smartphone and collecting data about general scrolling, typing, and tapping patterns. An 
application called DeepMood, for example, predicted depression on the basis of key presses and 
movements on the smartphone keyboard (Cao et al., 2017). Academic researchers are deploying these 
tools as well: Jacobson, Summers, and Wilhelm (2020) used a digital phenotyping approach combining 
machine learning methods with passively collected smartphone data about participants’ movement 
(via accelerometer) and social contact (via call and text records) to predict social anxiety symptoms. 
Smartwatches, smartrings, and fitness trackers (e.g. AppleWatch, Oura, FitBit) are increasingly 
being deployed in response to COVID-19, and can also be integrated with the kinds of apps described 
above. For example, Youper allows users to “integrate mindfulness sessions with Google Fit to make 
self-help and self-care easy.” Importantly, these wearable technologies also contain sensors not found 
in smartphones which could be relevant for mental health, including thermometers, and 
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photoplethysmography sensors (PPG) which use infrared light to measure changes in blood 
circulation, from which signals such heart rate variability can be derived (Castaneda et al., 2018). 
Finally, in what has been called a “landmark decision” (Robbins, 2020), the FDA has approved 
for the first time a video game app therapeutic - “EndeavorRx” developed by Akili Interactive Labs - 
meant to be prescribed to children with ADHD.6 
1.2 Social Media 
Given how much time many people spend on social media, digital approaches which can 
leverage the mental health-relevant data generated there have the potential to fill in gaps in the “clinical 
whitespace,” or the time between structured, formal interactions with healthcare systems 
(Coppersmith et al., 2017). Of course, one of the primary ways users access social media is through 
smartphone apps. Some early work in this vein was conducted De Choudhury and colleagues, who 
analyzed linguistic features from Facebook and Twitter posts to predict the onset of Major Depressive 
Disorder and postpartum depression (De Choudhury, Counts, Horvitz, Hoff, 2014), as well as 
constructing a general social media depression index (De Choudhury, Counts, & Horvitz, 2013).  
In a recent review, Chancellor & Choudhury (2020) describe 75 published studies which used various 
forms of social media data for inferring various mental health statuses. Most of the studies used data 
from Twitter, Reddit, and Weibo. By far, the most studied condition was depression, followed by 
suicide, schizophrenia, eating disorders, anxiety, stress, PTSD, and bipolar disorder. 
Some of the highest-profile work attempts to deploy text mining methods to predict suicide. 
Coppersmith et al. (2018), for example, utilize data from Twitter posts to aggregate risk scores from 
individual posts to predict a given user’s suicide risk. It is worth noting, however, that data gathered 
 
6 Interestingly, the game was in regulatory limbo for the past two years waiting on a decision from the FDA. But by the 
time the green light was given on June 15, 2020, the game was already available online, due to the FDA’s decision in April 
2020 to relax regulations on low-risk mental health devices during the COVID-19 pandemic. 
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from social media is not limited to text. In addition to psycholinguistic information contained in the 
text of social media posts, researchers can also extract mental health relevant signals from user-posted 
photos, in addition to meta-data such as the number, timing, and frequency of posts, geo-location, 
interactions with other users (e.g., follows, re-tweets, likes, replies, group memberships, etc.), or user 
network structures. 
1.3 Natural Language Processing (NLP) 
The example of text mining social media posts is part of a family of broader DMH applications 
which deploy computational methods on various speech and text corpora to investigate different 
aspects of mental health. These range from administrative tasks such as recording clinical notes, to 
diagnosis of mental disorders based on subtle syntactic features, to chat-bot delivered therapy, to 
automated reviews of clinical literature (see Shatte, Hutchinson, & Teague, 2019; Dreisbach, Koleck, 
Bourne, & Bakken, 2019 for reviews).  
For our purposes, one influential study in this area illustrates the predictive and diagnostic 
potential of DMH. Bedi et al. (2015) attempted to predict the onset of psychosis in high-risk youths. 
The researchers conducted open-ended interviews and then transcribed them into text. Using 
measures of semantic coherence, use of determiners (e.g. ‘that’, ‘what’, ‘whatever’, ‘which’) and phrase 
length, their machine learning classifier yielded 100% accuracy in predicting transition to psychosis, 
which outperformed the standard clinical ratings, which yielded only 79% accuracy. Corcoran et al. 
(2018) replicated and extended these findings with a larger sample, achieving 83% accuracy. Bedi et 
al. (2015, p. 2) note that “improving the capacity to predict psychosis among high-risk populations 
would have important ramifications for early identification and preventive intervention, potentially 
critically altering the long-term life trajectory of people with emergent psychotic disorders.” This sense 
of optimism for improving outcomes through early diagnosis is pervasive in the DMH literature and 
we will have more to say about it in Section 3 below. 
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Section 2: DMH as a response to COVID-19 
By March 2020, the global spread of COVID-19 required governments to impose sweeping 
public health interventions to reduce physical human contact in order to flatten the epidemiologic 
curve. Shortly thereafter, the U.S. government suspended some telehealth rules and regulations to 
quickly respond to social distancing requirements.7 These measures were widely lauded for being 
responsive to the safety needs of both health care professionals and patients (Shore et al., 2020). As 
Mosnaim et al. (2020) put it: “More changes in the adoption and administration of remote health care 
occurred in the first 20 days of March than in the previous 20 years to meet the health care crisis.” 
Researchers have, however, also expressed worries about the longer-term knock-on effects of 
social distancing, including increased anxiety, depression, serious mental illness, suicide and self-harm. 
(Reger, Stanley, & Joiner, 2020), in addition to alcohol and substance abuse, gambling, domestic and 
child abuse, along with psychosocial risks such as social disconnection, lack of meaning, feelings of 
entrapment, cyberbullying, feeling burdensome, financial stress, bereavement, loss, unemployment, 
homelessness, and relationship breakdown. (Holmes et al., 2020). According to Zhou et al. (2020, p. 
1), “the Chinese, Singaporean, and Australian governments have highlighted the psychological side 
effects of COVID-19, and have voiced concerns regarding the long-term impacts of isolation and that 
the fear and panic in the community could cause more harm than COVID-19.” 
A steady stream of articles and commentaries has since called for the wide-scale deployment 
of the tools described in Section 1 as a response to this growing crisis. For example, Torous et al. 
 
7 For example, Medicare quickly modified its policies to allow clinicians to use non-standard telehealth technologies such 
as FaceTime or Skype (Wilser, 2020) and also allowed clinicians to bill for them (Figueroa & Aguilera, 2020).  Likewise, 
the Health Insurance Portability and Accountability Act (HIPAA) Rules, immediately expanded the remote 
communication channels that health care professionals can use with patients, even if such channels do not fully comply 
with HIPAA (HIPAA OCR, 2020). Many states also waived the requirement of requiring psychiatrists to provide services 
only to patients within the states they are licensed to practice in, so they can now provide such services out of state (Gautam 
et al., 2020). 
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(2020, p. 1) proclaimed: “although the world today must ‘flatten the curve’ of spread of the virus, we 
argue that now is the time to ‘accelerate and bend the curve’ on digital health. Increased investments 
in digital health today will yield unprecedented access to high-quality mental health care.” Wind et al. 
(2020) called the COVID-19 pandemic, “the ‘black swan’ for mental health care and a turning point 
for e-health.” Robbins (2020) argued that the coronavirus pandemic “sets up a potential breakout 
moment for virtual mental health care.” Sust et al. (2020) urged mental health professions to “turn the 
crisis into an opportunity” by using digital mental health strategies. And indeed, one recent estimate 
suggests that broader uses of digital health technology during the pandemic drove a record $3.1B in 
investment (Rock Health, 2020). 
This much should be clear: We are at a turning point for DMH. Policymakers are proposing 
measures which could make permanent many digital health measures initially put in place as emergency 
responses to the pandemic. Choices made today will shape the future of mental healthcare for the 
foreseeable future. But which ethical considerations should guide these weighty decisions? We 
contend that they need to be (1) guided by evidence of efficacy and (2) responsive to the structural 
health inequalities laid bare by the pandemic.  
 
Section 3: Efficacy, justice, and the DMH response to COVID-19 
The existing literature on the ethics of DMH tends to focus on the different ethical standards 
between commercial and academic settings (Tourous & Roberts, 2017; Martinez-Martin & Kreitmair, 
2018), threats to autonomy (Burr & Morley, 2020), transparency and accountability (Martinez-Martin 
et al. 2018), data protection and data privacy (Morley et al., 2020; Chiauzzi & Wicks, 2019), informed 
consent (Martinez-Martin & Kreitmair, 2018; Morley et al., 2020), cultural differences (Tekin, 2020), 
among others. 
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Our central claim is that while these ethical considerations are important, they overlook a more 
fundamental ethical question which must be addressed in guiding the response to the pandemic: Do 
DMH technologies demonstrably improve mental health outcomes? If they do not, then many of these other 
ethical considerations will be moot. That is, if DMH technologies are highly unlikely to improve 
mental health outcomes (or if there is a risk of worsening such outcomes), then their widespread 
deployment as a response to the pandemic should be resisted on those grounds. And even if evidence 
does support the use of DMH, further questions about who benefits will still need to be addressed.  
3.1 Efficacy and DMH 
It is striking that, despite the existence of hundreds (if not thousands) of studies,8 there is no 
sustained engagement by bioethicists with the questions of whether and how DMH tools improve 
mental health outcomes, and for whom. The problem is obvious: Information about safety and 
efficacy is critical when weighing tradeoffs. People might be willing to take on certain data privacy 
risks, for example, in using a DMH app if there is a high probability that use of that app would 
significantly improve their mental health. But if the probability of improvement is low (or highly 
uncertain), then the data privacy risks might not be justifiable. In order to properly address such 
tradeoffs when making decisions about how to respond to the mental health fallout from COVID-
19, we need to carefully examine the existing body of empirical evidence.  
Specific answers to the question “Does DMH improve mental health outcomes?” will, of 
course, vary as function of the specific mental illness and the technology being considered. Moreover, 
mental health outcomes could be improved directly (by treatment or support) or indirectly (by early 
detection and diagnosis leading to better downstream treatments or support). 
 
8 For example, a recent meta-review by Lecomte et al. (2020) reported retrieving over 2,500 potential papers and 24 meta-
analyses related to DMH. 
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Still, for many of the technologies reviewed in Section 1, an overarching theme is clear: We 
simply don’t know if these technologies improve (or worsen) mental health outcomes, directly or 
indirectly, because the vast majority are not supported by empirical evidence. This is especially true for many 
smartphone apps, AI chatbots and wearables. 
To cite one of many examples, Larsen et al. (2019) reviewed the claims made by the 73 most 
highly rated mental health apps from the Google Play and iTunes apps stores. They found that less 
than half of the app descriptions employ scientific language, and of the apps describing specific scientific 
techniques, over 30% referred to techniques with no empirical support. Crucially, only two apps 
provided direct evidence associated with app use. 
There are, however, DMH technologies which have been rigorously evaluated with respect to 
mental health outcomes and we explore these in detail. We bring up the examples above to emphasize 
that such rigorous evaluation is the exception rather than the rule. 
Below, we focus mostly on smartphone apps for two reasons. First, this literature contains 
high-quality evidence directly assessing mental health outcomes. Second, the ubiquity and scalability 
of smartphone apps make them highly attractive candidates to address the mental health sequalae of 
COVID-19. While there is high-quality evidence directly assessing mental health outcomes for the 
kinds of tele-health approaches described above, these approaches tend to lack the scalability required 
to serve as effective responses to the pandemic (see footnote 3 above, also Section 3.3 below). 
Within the literature exploring the efficacy of smartphone apps, it would be easy to cherry-
pick a handful of studies showing that some smartphone-app-delivered therapy is more effective than 
traditional face-to-face therapy. It would be equally easy to cherry-pick a different handful of studies 
showing that some smartphone-app-delivered therapy makes users worse off than doing nothing at 
all. For this reason, we attempt to provide a balanced, big-picture view, using only the highest quality 
evidence from the field - meta-analyses of randomized controlled trials – to guide our ethical analyses.  
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3.1.1 Firth et al. (2017a) 
This was the first systematic evaluation of the empirical evidence for using smartphones to 
treat anxiety. The authors note that anxiety disorders are among the most prevalent mental health 
conditions across the globe, affecting nearly 30% of the population per year. They also tout familiar 
promises about smartphone interventions as highly scalable and personalizable. Their meta-analysis 
covered 9 Randomized Controlled Trials (RCTs) with a total of 1,581 participants, 880 of which were 
in various smartphone treatment conditions, and 701 of which were in various control conditions.  
The most coarse-grained analysis found a pooled effect size (i.e. the standardized mean 
difference between treatment and control conditions across all 9 RCTs) of g=0.325, with a 95% 
Confidence Interval (CI) ranging between 0.17-0.48, which is conventionally interpreted as a small-
to-moderate effect.9  
While the overall effect seems promising, more fine-grained sub-group analyses raise 
important concerns. When smartphone interventions were compared with “passive” waitlist controls 
(i.e., no engagement with a smartphone app) the effects were much larger (g=0.45) than when the 
smartphone interventions were compared with “active” controls (i.e., using a non-anxiety-treatment 
smartphone app) (g=0.19).  
In a theme that is present across many studies, when researchers employ a rigorous, active 
control condition (such as listening to music) which accounts for user attention and engagement with 
their smartphone, the effects of the interventions (in this case, for anxiety) are negligible or non-
 
9 Following Cohen (1992), effect sizes around 0.8 are considered large, effect sizes around 0.5 are moderate, and effect 
sizes around 0.2 are small. There are, however, perennial debates about the relationship between such measures of statistical 
significance on the one hand, and clinical significance on the other. In terms of interpreting the meta-analytic results 
reported here, a concrete example may be helpful. The 17-item Hamilton Depression Rating Scale, with a range from 0-
52 points, is “the most commonly used depression rating scale and is the recommended scale by psychiatrists worldwide” 
(Jakobsen, Gluud, & Kirsch (2019, p. 2). A decrease of three points on this scale (e.g. a score of 47 at baseline, and then a 
score of 44 after an intervention) corresponds to a standardized mean difference of 0.5. A drop of seven points on the 
scale corresponds to an effect size of around 0.8. For more context, Hieronymus, Jauhar, Østergaard, & Young (2020) 
estimate that commonly prescribed antidepressants have an effect size of approximately 0.3 compared with placebos. 
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existent. Similarly small results were found for studies which integrated smartphone interventions 
within a broader therapeutic context (e.g., in concert with face-to-face therapy, medications, etc.), but 
crucially, stand-alone smartphone apps which directly targeted anxiety did not differ significantly from controls.  
3.1.2 Firth et al. (2017b) 
This was the first systematic evaluation of the empirical evidence for using smartphones to 
treat depression. The authors note that depression impacts over 300 million people around the world, 
and that in countries like the USA, 9% of the population may have depression at any given time (Firth 
et al., 2017b, p. 287). This meta-analysis contained twice the number of interventions and participants, 
owing to the recent explosion of interest in DMH approaches to depression. Thus, 18 RCTs 
employing 22 different smartphone-delivered interventions, covering 3,414 participants were 
reviewed.  
The most coarse-grained analysis found a similar pooled effect size as in the anxiety studies 
(g=0.38, 95% CI: 0.24-0.52). But again, digging beneath the surface into the sub-group analyses 
provides important qualifications. Effect sizes for interventions with  compared with looser, inactive 
controls were significantly larger (g=0.55, 95% CI: 0.38-0.74) than the effect sizes for interventions 
compared with tighter, active control conditions (g=0.21, 95% CI: 0.10-0.33). While this is somewhat 
promising, the authors also note that “the only populations in which smartphone interventions 
significantly reduced depressive symptoms were those with self-reported mild-to-moderate 
depression” (p. 296).  
3.1.3 Linardon et al. (2019) 
As evidence of how quickly DMH is growing, consider that since the publication of Firth and 
colleagues’ meta-analyses, almost 50 more RCTs were published and included in the Linardon et al. 
(2019) meta-analysis, which included 66 RCTs with 77 smartphone interventions for a range of mental 
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health problems including anxiety, depression, stress, and post-traumatic stress disorder, among 
others. As with the meta-analyses above, only English language RCTs were included. 
Consistent with results above, the pooled effect size for 54 trials comparing smart-phone 
interventions and all control conditions for depression is g=0.28 (95% CI: 0.21-0.36), but sub-group 
analyses looking at smartphone interventions against “active” control conditions revealed a statistically 
insignificant effect size of g=0.13 (95% CI: –0.07 to 0.34), which ought to dampen some enthusiasm 
about the Firth et al. (2017b) results.   
Similar patterns obtained for generalized anxiety. The pooled effect size for 39 studies 
comparing smartphone interventions against all controls was g=0.30 (95% CI: 0.20-0.40). But again, 
when looking at “active” controls, the effect size drops to a statistically insignificant g=0.09 (95% CI: 
–0.21 to 0.39). Stress levels assessed in 27 comparison also exhibited the same patterns of results: The 
overall pooled effect g=0.35 (95% CI: 0.21-0.48) diminishes to a statistically insignificant g=0.21 (95% 
CI: –0.46 to 0.88) when compared with active controls. 
3.1.4 Wiesel et al. (2019) 
In this recent meta-analysis and systematic review, Weisel et al. (2019) focus specifically on 
standalone smartphone apps for a variety of mental health conditions including depression, anxiety, 
substance use, self-injurious thoughts and behaviors, and sleep problems. Their analysis covers 19 
RCTs involving 3,681 participants. 
The results for apps targeting depression are consistent with the meta-analyses above. In the 
present analysis, six comparisons (n = 796) yielded a significant pooled effect of g = 0.33 (95% CI 
0.10–0.57) with larger effect sizes observed when interventions were contrasted with passive controls 
g = 0.41 (95% CI 0.24–0.59), and, once again, non-significant effects for active controls g = 0.17 (95% 
CI −0.00 to 0.42). 
 14 
The pooled effect sizes for all the other conditions were, at best, small and statistically 
insignificant. For example, unlike previous findings, there was no significant difference between 
smartphone interventions and (any) control conditions for anxiety (g = .30, 95% CI −0.1 to 0.7).  
Strikingly, suicidal ideation was assessed in four comparisons (n = 286), and the negative effect 
size estimate (g =−0.14, 95% CI −0.37 to 0.1) suggests that, at best, smartphone interventions may do 
little to nothing, but at worst, they might sometimes lead to more suicidal ideation. Similar results were 
observed for three comparisons of self-injury (n = 225, g = −0.04, 95% CI −0.31 to 0.22), three 
comparisons of drinking behavior (n = 1040, g = −0.03, 95% CI −0.22 to 0.17), and one PTSD 
comparison (n = 49, g = −0.05, 95% CI −0.6 to 0.51). This suggest that not only might standalone 
apps for these conditions not improve outcomes very much, they may sometimes lead to worse outcomes. 
These results lead the authors to conclude that “there remains a lack of generalizable evidence 
to support particular standalone smartphone apps for mental health as a substitute to conventional 
mental health treatment,” which, in turn, highlights “the need for discussing the potential harm of 
currently available apps, which might keep users away from evidence-based interventions while 
bearing a substantial risk of being ineffective” (Weisel et al., 2019, p. 8). 
3.2 Interpretations and Qualifications 
While we have aimed to carefully present the best available evidence, some further 
qualifications are still necessary. First, it bears repeating that the overwhelming majority of DMH apps 
available on the market are not evidence-based. So, the small number of app-based interventions 
considered here are but a drop in the ocean. Still, there are several important methodological issues 
within this subset of apps which have been subject to empirical assessment. As many authors point 
out, a persistent risk of bias in the literature is due to difficulties with adequately blinding participants.10  
 
10 After all, if one signs up for a research study about the effects of a smartphone app on mental health, but one never 
uses an app (as in a waitlist control), or one just listens to music (as in an “active” control), it would not be difficult to 
determine that one was not in an intervention condition. 
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A related issue is that “digital placebo effects” are not well-characterized (Torous & Firth 
2016). Placebo effects play an important role in mental healthcare generally and this consideration 
looms especially large, given that many intervention effects of smartphone apps all but disappear when 
compared with active controls. 
Finally, an overarching consideration is the presence of trial bias. To see this, consider some 
of the results reported in Baumel, Edan, & Kane (2019). “Real world” data (as opposed to data 
collected in research settings) for app use suggests that only between 0.5% and 28.6% of users 
continue to use mental health apps after six weeks, whereas systematic reviews of research trials report 
completion rates of 50%–100%. For example, only 0.5% of the MoodGym apps’ native users 
completed a non-compulsory final assessment, where 22.5% completed it in a research trial (Fleming 
et al., 2018). Similarly for the PTSD Coach app: some participants in the trial reported using the app 
throughout the day, in different contexts, for 4 weeks. But in “real world” usage without interactions 
with researchers, almost half of the participants stopped using the app after one week (Owen et al., 
2015). 
Baumel, Edan, & Kane (2019) obtained independent and objective use data for mental health 
apps from SimilarWeb Pro, a mobile analytics company. They contrasted this “real world” data with 
data from 13 published research trials using the same apps and found that the median usage rate was 
over four times higher in the latter than the former.  
Despite this underwhelming evidence for direct efficacy, it is possible that smartphone apps 
or other DMH tools could improve mental health outcomes in other, less direct ways. For example, 
many of the NLP and data mining applications described in Section 1 deliver highly accurate 
predictions which promise earlier diagnosis and detection of disorders ranging from schizophrenia to 
Alzheimer’s. While many impressive results have been reported in this vein, DMH proponents often 
gloss too quickly over the myriad barriers that stand between the kinds of predictions generated by 
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various data mining approaches,  and the kinds of interventions that improve patient well-being.11 To 
see this, recall the Bedi et al. (2015) study from Section 1.3. No one would argue on the basis of their 
findings that a patient could decrease their risk of a psychotic episode by using longer phrases in their 
speech or altering their usage of words like “that” or “which”.12 And even if the only aim were to 
identify possible targets for early intervention, in the cases of psychosis-related conditions, there are 
very few effective treatments and interventions to which these early-identified patients could be 
referred (Friesen, 2019). In fact, following Burr, Morley, Taddeo, & Floridi (2020), it seems just as 
likely that the widespread use of these predictive techniques could lead to epidemiological inflation, 
diminishment of patient autonomy, and shifts in the distribution of responsibility for the maintenance 
of public mental health. 
Putting it all together, the evidence from the four meta-analyses above suggests that for the 
very small number of mental health apps that have been rigorously studied, the treatment effects are 
negligible to non-existent when considering the most relevant and informative comparisons with 
active controls. When this lack of efficacy is considered alongside pervasive methodological 
shortcomings (e.g., trial bias), unacknowledged difficulties in translating machine predictions to clinical 
interventions, as well as long-standing ethical concerns about data privacy, threats to autonomy, lack 
of transparency, and insufficient regulatory oversight, the case for smartphone apps as a response to 
the mental health fallout from COVID-19 is on thin ice. 
 
11 For a striking example of this gap between machine prediction and clinical intervention, see Elish & Watkins’s (2020) 
in-depth study of the Sepsis Watch AI tool deployed at the Duke Health. Their analysis shows that even with (relatively) 
straightforward conditions like sepsis, there exist tremendous difficulties in translating AI-driven predictions into 
improved clinical outcomes. Such difficulties are likely to be even more pronounced in the mental health context. 
 
12 One might object here that such NLP projects are more aimed at research than clinical application. However, when 
NLP researchers claim, as they often do, that such research can, for example, “greatly facilitate targeted early 
intervention” and “provide previously unavailable information for clinicians on which to base treatment and prognostic 
decisions” (Bedi et al., 2015, 6), it seems fair to raise this criticism, especially when the myriad difficulties of translating 
computational research into improved psychiatric outcomes are not discussed in any depth. See Velupillai et al. (2018) 




3.3 Efficacy and scalability 
As we have seen throughout, perhaps the most touted features of smartphone mental health 
interventions are their ubiquity and scalability. It is unsurprising then, in light of the kinds of headlines 
described in the Introduction, that they are portrayed as an attractive solution to the mental health 
fallout from COVID-19. And yet, the gaps described above severely limit the kinds of generalizability 
and scalability at the heart of many DMH proponents’ arguments for wide-scale adoption as a 
response to the pandemic.  
There are, of course, other forms of DMH which do enjoy more empirical support. As Torous, 
Myrick, Rauseo-Ricupero, & Firth (2020 p. 1) have pointed out, the temporary relaxation of many 
telehealth rules and regulations noted in Section 2 was “made possible because of the strong and clear 
evidence base for the efficacy of telehealth and decades of high-quality research.”13  
The problem, however, is that the forms of DMH (e.g., tele mental health) which enjoy the 
most robust empirical support are also the least scalable, and therefore the least likely to address the 
wide-ranging mental health sequalae from the pandemic.14 Indeed, as many clinicians have pointed out 
recently, telehealth is not a “turnkey” or “plug and play” affair. Extensive resources are required to 
establish the requisite digital infrastructure and competencies. 
On the flip side, DMH solutions like therapy apps or AI chatbots claim to provide resource-
effective alternatives. But the vast majority of these tools have not been subjected to empirical scrutiny. 
For those that have, the evidence suggests that most are about as effective as active controls, such as 
 
13 Here, they reference Yellowlees & Shore (2018). Studies examining the efficacy of telehealth via phone- or video-
calling vs. face-to-face therapy tend to point in the same direction for depression (Berryhill et al., 2018), PTSD (Acierno 
et al., 2017), and the use of internet-based cognitive behavioral therapy more generally (Andersson, Titov, Dear, 
Rozental, & Carlbring, 2019). 
 
14 In fact, these forms of tele-health may even be less time- and cost-effective than traditional face-to-face therapies, at 
least at first, given various struggles with internet connection issues, scheduling, interface functionality, and the like. Thanks 
to an anonymous reviewer for suggesting this point. 
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listening to music. Crucially, the evidence we reviewed above does support the limited efficacy of some 
apps for adjunctive or stepped-up care roles, but such concessions undermine their very motivation 
as a response to the pandemic: scalability. 
As policymakers are faced with difficult decisions about how to allocate limited resources for 
mental health, they will have to weigh many different considerations related to cost- and time-
effectiveness, along with a range of opportunity costs. Our analysis suggests that one particularly 
salient tradeoff will be between efficacy and scalability. That is, there seems to be an inverse 
relationship between the scalability of DMH tools and their likelihood of improving mental health 
outcomes.  
In turn, this presents a thorny problem: If the mental health fallout from the pandemic over 
the coming years is as widespread as is currently being predicted, then there will be an even greater 
shortage of mental health services relative to demand. Subsequently, we predict that calls for various 
DMH solutions to this problem will grow even louder. While the hype generated around DMH would 
have us believe that smartphone apps, AI chatbots, and the like are perfectly positioned to address 
this growing problem, the empirical evidence suggests that while these tools may indeed be able to 
achieve the requisite scale, they are highly unlikely to improve mental health outcomes – directly or 
indirectly - at that scale.  
Here, then, is one conclusion. In light of cuts to mental health budgets, limited public health 
resources should not be allocated to the longer-term development and deployment of smartphone-
app mental health interventions, as alluring and transformative as they might seem.15 This is especially 
 
15 To reiterate a point made above, evidence-based considerations do support the limited use of smartphone apps in 
stepped-up care settings, for example, and the same point might be made about the use of these technologies as “stopgap” 
solutions amid a public health emergency. This is fine as far as it goes. But we worry that many DMH proponents are 
advocating for much more than these short-term, emergency measures. Anticipating the themes of the next section, there 
is a real risk that, without persistent critical oversight, what starts as a short-term, “stopgap” solution slowly becomes the 
“new normal” in such a way that existing health inequalities are exacerbated: The relatively well-off in society get evidence-
based, face-to-face therapies while the less well-off get automated chatbot therapists. Indeed, in a recent op-ed, Green 
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true when such resources could be directed to (admittedly less sleek) established and evidence-based 
forms of tele-mental health. This is not to say that DMH tools have no place in the post-pandemic 
mental health ecosystem. To the contrary, we support the evidence-based deployment of these tools 
as adjuncts, or in stepped-up care settings. But we remain skeptical of the recent and more ambitious 
assessments of the transformative potential of these technologies as a response to the pandemic. 
3.4 Justice and DMH  
Mental illness makes up 13–16% of the total global burden of disease, and it was well-known 
before the pandemic that this disease burden is disproportionately high in low-income areas (Vigo, 
Thornicroft, & Atun, 2016; Collins et al., 2011; Ngui, Khasakhala, Ndetei, & Roberts, 2010). Similarly, 
Cook et al. (2017) report significant disparities in racial and ethnic minority groups’ access to various 
mental health services compared to Whites, and for Blacks and Hispanics, these disparities widened 
between 2004 – 2012. It is with these kinds of findings in mind that a widely-cited position paper in 
Lancet Psychiatry predicted that the pandemic would “exacerbate healthcare disparities and will probably 
disproportionately affect socially disadvantaged patients,” and that “health systems will be faced with 
widespread demand to address these COVID-19-related mental health needs” (Moreno et al., 2020, 
p. 1). 
It is too early to say for certain whether these predictions will be borne out. However, recent 
evidence from a carefully designed longitudinal study has shown a significant increase in mental 
distress in the UK population attributable to COVID-19 which has “not affected all groups equally” 
such that “established health inequalities persist” (Pierce et al., 2020, p. 884). Czeisler et al. (2020) 
reported a broadly similar pattern of results in the US, with disproportionately worse mental health 
outcomes experienced by racial/ethnic minorities, essential workers, and unpaid adult caregivers. 
 
(2020) observes precisely this dynamic, albeit in the context of primary education, in proposals for so-called “learning 
pods”. 
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Many DMH interventions explicitly target these disparities, but there is a persistent risk that 
they may exacerbate the very problems they aim to fix. Scholars from many disciplines have examined 
this risk through the lens of the digital divide. In the present context, there are at least three 
manifestations of the digital divide relevant to the DMH response to COVID-19. 
The first refers to the unequal access to DMH tools between those that can afford mobile 
technologies and reliable high-speed internet access and those who cannot. (Anthes, 2016, p. 23). A 
second concerns unequal engagement with DMH tools between those are digitally literate (or 
motivated to become more digitally literate) and those who are not (Terrasse et al., 2018). A third is 
what McCarthy (2016) calls a “big data divide” and refers to the disparity between organizations that 
have the financial and technical means to collect, link, and analyze big data as opposed to those who 
lack such resources and capabilities. Organizations with greater access to higher volumes and higher 
quality mental health relevant data are thus able to develop tools and uncover insights that more “data 
poor” organizations are not. As McCarthy (2016, p. 1132) points out, perhaps unsurprisingly, these 
various digital divides are driven by customary markers of inequality such as “income, education, race, 
gender, and area of residence.” 
All of this raises the worry that even the best evidence-based DMH tools have the potential 
to lock-in vicious cycles of digital inequality, whereby those with fewer digital resources and lower 
digital literacy will be excluded from advances in evidence-based DMH technology. This in turn makes 
it less likely that their mental health issues will be improved, which could lead to further disadvantages 
of resources and literacy, and so on.  
The heart of the concern raised in Section 3.3 is that limited public health resources should 
not be allocated to DMH technologies which are not likely, on the basis of existing empirical evidence, 
to improve mental health outcomes. Keeping in mind the qualifications from Section 3.2, this covers 
many, but not all, of the DMH approaches reviewed in Section 1. Importantly, evidence-based 
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considerations do support the use of tele mental health as a response to the pandemic (scalability issues 
notwithstanding). In turn, however, this raises several questions about digital divides which must be 
reckoned with. 
As we mentioned, telehealth is not a simple switch that clinicians can turn on or off. As Torous 
& Wykes (2020, p. 1) note, developing effective “webside manner” requires a substantial investment 
of resources: 
The benefits of increased access to telehealth services are apparent for telepsychiatry, but in 
the present crisis, these benefits can only be realized if these digital tools are used by clinicians 
who have the appropriate training and guidance and know these services are accepted by 
organizations providing services and payers. The need for training among health care professionals is 
the number 1 priority” (emphasis added). 
A corollary here is that organizations with the requisite resources (money, time, supervision, 
infrastructure, etc.) are better positioned to switch to telehealth than those with fewer resources. 
Surprisingly, some recent reporting has suggested that while many practices quickly adopted telehealth 
at the outset of the pandemic, many are now abandoning it. More specifically, organizations with more 
than 100 clinicians were able to shift 16% of their pre-pandemic visits to telehealth visits, while 
organizations with 20 or fewer clinicians were barely able to shift 5% (Mehrotra, Linetsky, & Hatch, 
2020). Perhaps less surprising is that many of these smaller organizations often serve less privileged 
populations.  
The worries about widening digital divides should be clear: mental health practices with more 
resources, serving more well-off patients, are more likely to provide high quality telehealth during and 
after the pandemic than those practices with fewer resources, serving less well-off patients. In turn, 
this makes it less likely that the less well-off will see improvements in their mental health, and again, 
on down the spiral. 
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Moreover, as Wetsman (2020) has documented, many design choices in telehealth interfaces 
are made by English speakers for English speakers. So while telehealth may be effective for social 
distancing reasons, and while some populations may prefer it, for the 25 million people in the US who 
have limited English language skills, some forms of telehealth could prove more of a barrier than a 
benefit.16 And because these populations are more likely to be poor and work in jobs at higher risk of 
COVID-19 exposure, the potential for widening health inequalities is ever present. 
Similarly, elderly people are among the highest-risk for serious illness or death from COVID-
19 (CDC, 2020), suffer from high rates of social isolation and loneliness (Holt-Lundstad, Robles, & 
Sbarra, 2017), and crucially for our purposes, are also among the least likely to benefit from advances in DMH.  
Data from the Pew Research Center shows that only 42% of adults age 65 or older have 
smartphones and only 51% of adults age 65 or older have high-speed internet at home (Pew, 2017). 
While these numbers are likely somewhat higher now, the fact remains that many DMH tools are not 
designed with elderly users in mind, and there are substantial barriers for the elderly to engage with 
and benefit from them (Seifert, Reinwand, & Schlomann, 2019). 
Against the backdrop of the stark, pre-existing health disparities laid bare by the pandemic 
(e.g., Yancy, 2020; Chowkwanyan & Reed, 2020), these worries about resource inequalities among 
providers and various language and digital literacy barriers among patients force a serious 
consideration of whether widescale adoption of DMH will narrow or widen these gaps. We think there 
is a substantial risk that the gaps will widen. 
But more than that, we must also seriously consider whether some DMH tools might 
themselves be perpetuating the very problems they aim to solve. Consider that Facebook deploys 
algorithms to assess the suicide risk of users on its platform (de Andrade et al., 2018). When the 
 
16 These worries are pronounced in other forms of DMH as well, especially NLP applications which are trained only or 
primarily on English speakers’ voice, text, social media posts, etc. 
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algorithm and a moderator identify crisis situations, police officers are often dispatched to conduct 
wellness checks. In 2018 alone, Facebook initiated 3,500 such wellness checks. But as the tragic cases 
of D'Andre Campbell, Ejaz Ahmed Choudry, and Chantel Moore illustrate, for Black and Indigenous 
communities, wellness checks can be fatal: all were shot and killed during wellness checks by police in 
Canada between April and June 2020. 
Here, then, is another conclusion. At the very least, we need to ensure that DMH tools do not 
exacerbate various forms of inequality. And to the extent that DMH tools are deployed, we also need 
to ensure that the necessary resources, such as clinician training, digital literacy, reliable broadband, 
access to stepped-up care, etc., are made available to bring their use in-line with evidence-based 
standards. This, of course, requires longer-term investments aimed at addressing the structural barriers 




17 Thanks to Walter Sinnott-Armstrong, Jana Schaich Borg, and members of MAD Lab for their helpful feedback on 
earlier drafts of this manuscript. Thanks also to two anonymous referees. Their careful comments helped to strengthen 
and clarify our arguments. 
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